| Annual Financials | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 3 | 5 | 16 | 34 | 0 |
| Expenses | 2 | 4 | 12 | 27 | 0 |
| EBITDA | 1 | 1 | 4 | 7 | 0 |
| Operating Profit % | 21 % | 24 % | 23 % | 21 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 0 |
| Profit Before Tax | 0 | 1 | 3 | 6 | 0 |
| Tax | 0 | 0 | 1 | 1 | 0 |
| Net Profit | 0 | 1 | 3 | 5 | 0 |
| EPS in ₹ | 7.79 | 22.83 | 71.91 | 9.35 | 0.00 |
Accretion Nutraveda
Accretion Nutraveda
268.50
+7.00
(2.68%)
Market Cap
194.37 Cr
PE Ratio
-
Volume
7,000.00
Day High - Low
268.50 - 248.45
52W High-Low
300.00 - 150.10
Key Fundamentals
Market Cap
194.37 Cr
EPS
9.35
PE Ratio
-
PB Ratio
6.17
Book Value
42.41
EBITDA
6.89
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
48.85
Debt to Equity
0.94
Actual
Company News
View All News
Accretion Nutraveda Limited has scheduled a board meeting on May 8, 2026, to consider and approve audited financial results for the year ended March 31, 2026.
Accretion Nutraveda Limited filed its quarterly certificate under SEBI Regulation 74(5) for Q4FY26, confirming all shares remain in dematerialized form with no rematerialization requests received during the period.
Accretion Nutraveda Limited notifies BSE about Corporate Identification Number update from U24290GJ2021PLC121216 to L24290GJ2021PLC121216 following its equity shares listing on BSE SME Exchange on 04th February, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,790.40 | #1 4,29,576.93 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.62 | |
6,570.00 | 1,74,412.86 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 44.07 | |
4,365.00 | 1,47,731.43 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 46.97 | |
1,373.30 | 1,10,932.52 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 53.76 | |
1,075.70 | 1,08,240.59 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 69.53 | |
1,261.00 | 1,05,248.48 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 43.69 | |
2,259.20 | 1,03,255.20 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 42.84 | |
2,372.50 | 97,938.00 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 42.75 | |
1,437.50 | 83,490.23 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 46.16 | |
1,392.50 | 75,175.03 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 74.67 |
Growth Rate
Revenue Growth
108.70 %
Net Income Growth
95.00 %
Cash Flow Change
-1,060.87 %
ROE
-35.52 %
ROCE
-28.89 %
EBITDA Margin (Avg.)
-13.10 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 4 | 5 | 11 | 42 |
| Fixed Assets | 2 | 1 | 2 | 2 |
| Current Assets | 3 | 3 | 9 | 36 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 9 |
| Other Assets | 3 | 3 | 9 | 0 |
| Total Equity & Liabilities | 4 | 5 | 11 | 42 |
| Current Liabilities | 2 | 3 | 4 | 3 |
| Non Current Liabilities | 1 | 1 | 2 | 4 |
| Total Equity | 0 | 1 | 5 | 36 |
| Reserve & Surplus | -0 | 1 | 5 | 28 |
| Share Capital | 0 | 0 | 1 | 7 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | -0 |
| Investing Activities | 0 | -0 | -1 |
| Operating Activities | 1 | 0 | -2 |
| Financing Activities | -1 | 0 | 3 |
Share Holding
| % Holding | Sept 2025 | Jan 2026 | Feb 2026 | Mar 2026 |
| Promoter | 100.00 % | 100.00 % | 73.48 % | 73.48 % |
| FIIs | 0.00 % | 0.00 % | 6.04 % | 1.08 % |
| DIIs | 0.00 % | 0.00 % | 6.51 % | 7.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 10.48 % | 14.19 % |
| Others | 0.00 % | 0.00 % | 3.49 % | 4.25 % |
| No of Share Holders | 10 | 10 | 407 | 427 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 May 2026 |  Quarterly Result Announcement | NA | 08 May 2026 | 267.50 | 271.70 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release
May 15, 2026
May 15, 2026Appointment Of Internal AuditorsMay 08, 2026
May 08, 2026Appointment Of Secretarial AuditorsMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 08, 2026
May 08, 2026Board Meeting Outcome for Outcome Of Board Meeting Financial Results 31St March 2026May 08, 2026
May 08, 2026Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Audited Financial Results For The Year Ended On 31St March 2026May 01, 2026
May 01, 2026Clarification On Price MovementApr 30, 2026
Apr 30, 2026Clarification sought from Accretion Nutraveda LtdApr 29, 2026
Apr 29, 2026Confirmation Regarding Non-Applicability Of Large Corporate Disclosure RequirementsApr 29, 2026
Apr 29, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Apr 27, 2026
Apr 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Apr 04, 2026Intimation For Change Of Corporate Identification Number (CIN) Of The Company.Apr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 28, 2026
Mar 28, 2026Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 26, 2026
Mar 26, 2026Appointment Of Internal AuditorsMar 26, 2026
Mar 26, 2026Board Meeting Outcome for Outcome Of The Board MeetingMar 26, 2026
Mar 26, 2026Clarification On Price MovementFeb 20, 2026
Feb 20, 2026Clarification sought from Accretion Nutraveda LtdFeb 19, 2026
Feb 19, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 17, 2026
Feb 17, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 07, 2026
Feb 07, 2026Listing of Equity Shares of Accretion Nutraveda LtdFeb 04, 2026
Feb 04, 2026Technical Indicators
RSI(14)
Neutral 57.08
ATR(14)
Less Volatile 16.57
STOCH(9,6)
Neutral 32.10
STOCH RSI(14)
Oversold 10.07
MACD(12,26)
Bearish -2.76
ADX(14)
Strong Trend 30.98
UO(9)
Bearish 51.64
ROC(12)
Uptrend And Accelerating 3.16
WillR(14)
Neutral -66.49
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
